This report contains market size and forecasts of Cefotaxime Sodium API in global, including the following market information:
Global Cefotaxime Sodium API Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Cefotaxime Sodium API Market Sales, 2016-2021, 2022-2027, (MT)
Global top five Cefotaxime Sodium API companies in 2020 (%)
The global Cefotaxime Sodium API market was valued at 105.1 million in 2020 and is projected to reach US$ 101.9 million by 2027, at a CAGR of -0.8% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cefotaxime Sodium API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cefotaxime Sodium API Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Cefotaxime Sodium API Market Segment Percentages, By Type, 2020 (%)
ChP
USP
EP
Global Cefotaxime Sodium API Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Cefotaxime Sodium API Market Segment Percentages, By Application, 2020 (%)
Single Injection
Compound Injection
Global Cefotaxime Sodium API Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Cefotaxime Sodium API Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cefotaxime Sodium API revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Cefotaxime Sodium API revenues share in global market, 2020 (%)
Key companies Cefotaxime Sodium API sales in global market, 2016-2021 (Estimated), (MT)
Key companies Cefotaxime Sodium API sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
REYOUNG
Nectar Lifesciences
Medya Pharma
Sandoz
Kelun
NCPC
Aurobindo Pharma
United Laboratories
Orchid Pharma
CSPC
Kopran
Covalent
ACS Dobfar
Dawnrays
Sterile India
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Cefotaxime Sodium API Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cefotaxime Sodium API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cefotaxime Sodium API Overall Market Size
2.1 Global Cefotaxime Sodium API Market Size: 2021 VS 2027
2.2 Global Cefotaxime Sodium API Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Cefotaxime Sodium API Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Cefotaxime Sodium API Players in Global Market
3.2 Top Global Cefotaxime Sodium API Companies Ranked by Revenue
3.3 Global Cefotaxime Sodium API Revenue by Companies
3.4 Global Cefotaxime Sodium API Sales by Companies
3.5 Global Cefotaxime Sodium API Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Cefotaxime Sodium API Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Cefotaxime Sodium API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cefotaxime Sodium API Players in Global Market
3.8.1 List of Global Tier 1 Cefotaxime Sodium API Companies
3.8.2 List of Global Tier 2 and Tier 3 Cefotaxime Sodium API Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Cefotaxime Sodium API Market Size Markets, 2021 & 2027
4.1.2 ChP
4.1.3 USP
4.1.4 EP
4.2 By Type - Global Cefotaxime Sodium API Revenue & Forecasts
4.2.1 By Type - Global Cefotaxime Sodium API Revenue, 2016-2021
4.2.2 By Type - Global Cefotaxime Sodium API Revenue, 2022-2027
4.2.3 By Type - Global Cefotaxime Sodium API Revenue Market Share, 2016-2027
4.3 By Type - Global Cefotaxime Sodium API Sales & Forecasts
4.3.1 By Type - Global Cefotaxime Sodium API Sales, 2016-2021
4.3.2 By Type - Global Cefotaxime Sodium API Sales, 2022-2027
4.3.3 By Type - Global Cefotaxime Sodium API Sales Market Share, 2016-2027
4.4 By Type - Global Cefotaxime Sodium API Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cefotaxime Sodium API Market Size, 2021 & 2027
5.1.2 Single Injection
5.1.3 Compound Injection
5.2 By Application - Global Cefotaxime Sodium API Revenue & Forecasts
5.2.1 By Application - Global Cefotaxime Sodium API Revenue, 2016-2021
5.2.2 By Application - Global Cefotaxime Sodium API Revenue, 2022-2027
5.2.3 By Application - Global Cefotaxime Sodium API Revenue Market Share, 2016-2027
5.3 By Application - Global Cefotaxime Sodium API Sales & Forecasts
5.3.1 By Application - Global Cefotaxime Sodium API Sales, 2016-2021
5.3.2 By Application - Global Cefotaxime Sodium API Sales, 2022-2027
5.3.3 By Application - Global Cefotaxime Sodium API Sales Market Share, 2016-2027
5.4 By Application - Global Cefotaxime Sodium API Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Cefotaxime Sodium API Market Size, 2021 & 2027
6.2 By Region - Global Cefotaxime Sodium API Revenue & Forecasts
6.2.1 By Region - Global Cefotaxime Sodium API Revenue, 2016-2021
6.2.2 By Region - Global Cefotaxime Sodium API Revenue, 2022-2027
6.2.3 By Region - Global Cefotaxime Sodium API Revenue Market Share, 2016-2027
6.3 By Region - Global Cefotaxime Sodium API Sales & Forecasts
6.3.1 By Region - Global Cefotaxime Sodium API Sales, 2016-2021
6.3.2 By Region - Global Cefotaxime Sodium API Sales, 2022-2027
6.3.3 By Region - Global Cefotaxime Sodium API Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Cefotaxime Sodium API Revenue, 2016-2027
6.4.2 By Country - North America Cefotaxime Sodium API Sales, 2016-2027
6.4.3 US Cefotaxime Sodium API Market Size, 2016-2027
6.4.4 Canada Cefotaxime Sodium API Market Size, 2016-2027
6.4.5 Mexico Cefotaxime Sodium API Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Cefotaxime Sodium API Revenue, 2016-2027
6.5.2 By Country - Europe Cefotaxime Sodium API Sales, 2016-2027
6.5.3 Germany Cefotaxime Sodium API Market Size, 2016-2027
6.5.4 France Cefotaxime Sodium API Market Size, 2016-2027
6.5.5 U.K. Cefotaxime Sodium API Market Size, 2016-2027
6.5.6 Italy Cefotaxime Sodium API Market Size, 2016-2027
6.5.7 Russia Cefotaxime Sodium API Market Size, 2016-2027
6.5.8 Nordic Countries Cefotaxime Sodium API Market Size, 2016-2027
6.5.9 Benelux Cefotaxime Sodium API Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Cefotaxime Sodium API Revenue, 2016-2027
6.6.2 By Region - Asia Cefotaxime Sodium API Sales, 2016-2027
6.6.3 China Cefotaxime Sodium API Market Size, 2016-2027
6.6.4 Japan Cefotaxime Sodium API Market Size, 2016-2027
6.6.5 South Korea Cefotaxime Sodium API Market Size, 2016-2027
6.6.6 Southeast Asia Cefotaxime Sodium API Market Size, 2016-2027
6.6.7 India Cefotaxime Sodium API Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Cefotaxime Sodium API Revenue, 2016-2027
6.7.2 By Country - South America Cefotaxime Sodium API Sales, 2016-2027
6.7.3 Brazil Cefotaxime Sodium API Market Size, 2016-2027
6.7.4 Argentina Cefotaxime Sodium API Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Cefotaxime Sodium API Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Cefotaxime Sodium API Sales, 2016-2027
6.8.3 Turkey Cefotaxime Sodium API Market Size, 2016-2027
6.8.4 Israel Cefotaxime Sodium API Market Size, 2016-2027
6.8.5 Saudi Arabia Cefotaxime Sodium API Market Size, 2016-2027
6.8.6 UAE Cefotaxime Sodium API Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 REYOUNG
7.1.1 REYOUNG Corporate Summary
7.1.2 REYOUNG Business Overview
7.1.3 REYOUNG Cefotaxime Sodium API Major Product Offerings
7.1.4 REYOUNG Cefotaxime Sodium API Sales and Revenue in Global (2016-2021)
7.1.5 REYOUNG Key News
7.2 Nectar Lifesciences
7.2.1 Nectar Lifesciences Corporate Summary
7.2.2 Nectar Lifesciences Business Overview
7.2.3 Nectar Lifesciences Cefotaxime Sodium API Major Product Offerings
7.2.4 Nectar Lifesciences Cefotaxime Sodium API Sales and Revenue in Global (2016-2021)
7.2.5 Nectar Lifesciences Key News
7.3 Medya Pharma
7.3.1 Medya Pharma Corporate Summary
7.3.2 Medya Pharma Business Overview
7.3.3 Medya Pharma Cefotaxime Sodium API Major Product Offerings
7.3.4 Medya Pharma Cefotaxime Sodium API Sales and Revenue in Global (2016-2021)
7.3.5 Medya Pharma Key News
7.4 Sandoz
7.4.1 Sandoz Corporate Summary
7.4.2 Sandoz Business Overview
7.4.3 Sandoz Cefotaxime Sodium API Major Product Offerings
7.4.4 Sandoz Cefotaxime Sodium API Sales and Revenue in Global (2016-2021)
7.4.5 Sandoz Key News
7.5 Kelun
7.5.1 Kelun Corporate Summary
7.5.2 Kelun Business Overview
7.5.3 Kelun Cefotaxime Sodium API Major Product Offerings
7.5.4 Kelun Cefotaxime Sodium API Sales and Revenue in Global (2016-2021)
7.5.5 Kelun Key News
7.6 NCPC
7.6.1 NCPC Corporate Summary
7.6.2 NCPC Business Overview
7.6.3 NCPC Cefotaxime Sodium API Major Product Offerings
7.6.4 NCPC Cefotaxime Sodium API Sales and Revenue in Global (2016-2021)
7.6.5 NCPC Key News
7.7 Aurobindo Pharma
7.7.1 Aurobindo Pharma Corporate Summary
7.7.2 Aurobindo Pharma Business Overview
7.7.3 Aurobindo Pharma Cefotaxime Sodium API Major Product Offerings
7.4.4 Aurobindo Pharma Cefotaxime Sodium API Sales and Revenue in Global (2016-2021)
7.7.5 Aurobindo Pharma Key News
7.8 United Laboratories
7.8.1 United Laboratories Corporate Summary
7.8.2 United Laboratories Business Overview
7.8.3 United Laboratories Cefotaxime Sodium API Major Product Offerings
7.8.4 United Laboratories Cefotaxime Sodium API Sales and Revenue in Global (2016-2021)
7.8.5 United Laboratories Key News
7.9 Orchid Pharma
7.9.1 Orchid Pharma Corporate Summary
7.9.2 Orchid Pharma Business Overview
7.9.3 Orchid Pharma Cefotaxime Sodium API Major Product Offerings
7.9.4 Orchid Pharma Cefotaxime Sodium API Sales and Revenue in Global (2016-2021)
7.9.5 Orchid Pharma Key News
7.10 CSPC
7.10.1 CSPC Corporate Summary
7.10.2 CSPC Business Overview
7.10.3 CSPC Cefotaxime Sodium API Major Product Offerings
7.10.4 CSPC Cefotaxime Sodium API Sales and Revenue in Global (2016-2021)
7.10.5 CSPC Key News
7.11 Kopran
7.11.1 Kopran Corporate Summary
7.11.2 Kopran Cefotaxime Sodium API Business Overview
7.11.3 Kopran Cefotaxime Sodium API Major Product Offerings
7.11.4 Kopran Cefotaxime Sodium API Sales and Revenue in Global (2016-2021)
7.11.5 Kopran Key News
7.12 Covalent
7.12.1 Covalent Corporate Summary
7.12.2 Covalent Cefotaxime Sodium API Business Overview
7.12.3 Covalent Cefotaxime Sodium API Major Product Offerings
7.12.4 Covalent Cefotaxime Sodium API Sales and Revenue in Global (2016-2021)
7.12.5 Covalent Key News
7.13 ACS Dobfar
7.13.1 ACS Dobfar Corporate Summary
7.13.2 ACS Dobfar Cefotaxime Sodium API Business Overview
7.13.3 ACS Dobfar Cefotaxime Sodium API Major Product Offerings
7.13.4 ACS Dobfar Cefotaxime Sodium API Sales and Revenue in Global (2016-2021)
7.13.5 ACS Dobfar Key News
7.14 Dawnrays
7.14.1 Dawnrays Corporate Summary
7.14.2 Dawnrays Business Overview
7.14.3 Dawnrays Cefotaxime Sodium API Major Product Offerings
7.14.4 Dawnrays Cefotaxime Sodium API Sales and Revenue in Global (2016-2021)
7.14.5 Dawnrays Key News
7.15 Sterile India
7.15.1 Sterile India Corporate Summary
7.15.2 Sterile India Business Overview
7.15.3 Sterile India Cefotaxime Sodium API Major Product Offerings
7.15.4 Sterile India Cefotaxime Sodium API Sales and Revenue in Global (2016-2021)
7.15.5 Sterile India Key News
8 Global Cefotaxime Sodium API Production Capacity, Analysis
8.1 Global Cefotaxime Sodium API Production Capacity, 2016-2027
8.2 Cefotaxime Sodium API Production Capacity of Key Manufacturers in Global Market
8.3 Global Cefotaxime Sodium API Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Cefotaxime Sodium API Supply Chain Analysis
10.1 Cefotaxime Sodium API Industry Value Chain
10.2 Cefotaxime Sodium API Upstream Market
10.3 Cefotaxime Sodium API Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cefotaxime Sodium API Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Cefotaxime Sodium API in Global Market
Table 2. Top Cefotaxime Sodium API Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Cefotaxime Sodium API Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Cefotaxime Sodium API Revenue Share by Companies, 2016-2021
Table 5. Global Cefotaxime Sodium API Sales by Companies, (MT), 2016-2021
Table 6. Global Cefotaxime Sodium API Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Cefotaxime Sodium API Price (2016-2021) & (USD/MT)
Table 8. Global Manufacturers Cefotaxime Sodium API Product Type
Table 9. List of Global Tier 1 Cefotaxime Sodium API Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cefotaxime Sodium API Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type